We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$425M
AUM Growth
-$75.9M
Cap. Flow
-$88.8M
Cap. Flow %
-20.87%
Top 10 Hldgs %
54.69%
Holding
34
New
5
Increased
6
Reduced
22
Closed
1

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.37M
2
CI icon
Cigna
CI
+$8.82M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.6M
4
INCY icon
Incyte
INCY
+$5.13M
5
BNTX icon
BioNTech
BNTX
+$3.57M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.8M
2
BAX icon
Baxter International
BAX
+$19.1M
3
PFE icon
Pfizer
PFE
+$18.1M
4
XRAY icon
Dentsply Sirona
XRAY
+$7.51M
5
QGEN icon
Qiagen
QGEN
+$7.21M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$315B
$36.5M 8.57%
475,804
-337,010
-41% -$26.8M
INCY icon
2
Incyte
INCY
$23.4B
$27.8M 6.54%
378,852
+76,113
+25% +$5.13M
CAH icon
3
Cardinal Health
CAH
$53.5B
$25.6M 6.01%
496,680
-26,926
-5% -$1.32M
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$21.7M 5.11%
348,591
-96,419
-22% -$5.66M
GILD icon
5
Gilead Sciences
GILD
$167B
$21.6M 5.07%
297,055
-74,030
-20% -$5.1M
CVS icon
6
CVS Health
CVS
$137B
$21.3M 5%
206,162
+30,042
+17% +$2.78M
BSX icon
7
Boston Scientific
BSX
$65.4B
$21.2M 4.99%
499,530
-103,152
-17% -$4.33M
MDT icon
8
Medtronic
MDT
$106B
$21.1M 4.97%
204,268
+19,568
+11% +$2.27M
BDX icon
9
Becton Dickinson
BDX
$43.6B
$19M 4.47%
77,538
-6,095
-7% -$1.46M
PFE icon
10
Pfizer
PFE
$143B
$16.9M 3.96%
285,403
-366,197
-56% -$18.1M
BIIB icon
11
Biogen
BIIB
$30.4B
$16M 3.76%
66,599
-16,720
-20% -$4.3M
ELV icon
12
Elevance Health
ELV
$80.9B
$15.9M 3.75%
34,402
-8,790
-20% -$3.7M
CNC icon
13
Centene
CNC
$32.8B
$15.1M 3.55%
183,146
-29,077
-14% -$2.13M
BRKR icon
14
Bruker
BRKR
$8.86B
$13.7M 3.21%
162,768
-70,484
-30% -$5.65M
OGN icon
15
Organon & Co
OGN
$3.55B
$13.1M 3.09%
431,709
-114,353
-21% -$3.72M
NUVA
16
DELISTED
NuVasive, Inc.
NUVA
$12.6M 2.97%
240,691
-57,735
-19% -$3.14M
QGEN icon
17
Qiagen
QGEN
$8.49B
$10.9M 2.57%
185,636
-125,780
-40% -$7.21M
BMRN icon
18
BioMarin Pharmaceuticals
BMRN
$11.5B
$10M 2.36%
+113,548
New +$9.37M
ELAN icon
19
Elanco Animal Health
ELAN
$12.9B
$9.8M 2.3%
345,230
-64,501
-16% -$2.01M
CI icon
20
Cigna
CI
$74.5B
$9.53M 2.24%
+41,500
New +$8.82M
BIO icon
21
Bio-Rad Laboratories Class A
BIO
$8.15B
$8.79M 2.07%
11,639
+384
+3% +$287K
VRTX icon
22
Vertex Pharmaceuticals
VRTX
$123B
$8.58M 2.02%
+39,069
New +$7.6M
LH icon
23
Labcorp
LH
$23.2B
$7.34M 1.73%
27,211
-16,856
-38% -$4.17M
XRAY icon
24
Dentsply Sirona
XRAY
$2.81B
$6.41M 1.51%
114,816
-136,514
-54% -$7.51M
IONS icon
25
Ionis Pharmaceuticals
IONS
$8.99B
$6.38M 1.5%
209,537
-54,333
-21% -$1.71M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2021 Portfolio in Review

As of Q4 2021, Sector Gamma AS held 34 positions worth $425M, down 15% from $501M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Sector Gamma AS withdrew a net $88.8M in Q4 2021, closing 1 position and reducing 22 holdings. Its most notable exit was Baxter International, an estimated $19.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in BioMarin Pharmaceuticals worth $10M.

  • Sector Gamma AS's largest Q4 2021 buy was BioMarin Pharmaceuticals: 113,548 shares worth $10M.
  • Sector Gamma AS added most to Incyte in Q4 2021, an estimated $5.13M increase.
  • Sector Gamma AS's biggest Q4 2021 reduction was Merck, cutting an estimated $26.8M.
  • Sector Gamma AS fully exited Baxter International in Q4 2021, selling an estimated $19.1M.
  • Sector Gamma AS's ten largest holdings make up 55% of its $425M portfolio in Q4 2021.
  • Sector Gamma AS opened 5 new positions and closed 1 in Q4 2021.
  • Sector Gamma AS's portfolio value fell 15% quarter-over-quarter to $425M.

Based on Sector Gamma AS's 13F filing for Q4 2021, filed 8 Feb 2022.